InvestorsHub Logo
Followers 8
Posts 440
Boards Moderated 0
Alias Born 04/02/2013

Re: lasers post# 35313

Friday, 05/20/2016 9:43:53 AM

Friday, May 20, 2016 9:43:53 AM

Post# of 48316
The Streets Adam Feurstein basically said it had better data than Ziopharm -ziop and had a negative valuation. He argued ziop was way too expensive compared to oncosec which had better data. Drawing a lot of attention to oncosec today